医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
3-嘧啶-2-基苯基异氰酸酯 | 2-(3-Isocyanatophenyl)pyrimidine | 898289-49-1 | C11H7N3O |
|
3-嘧啶-2-基-苯甲醛 | 3-(pyrimidin-2-yl)benzoic acid | 579476-26-9 | C11H8N2O2 |
|
3-嘧啶-2-基-丙酸 | 3-(pyrimidin-2-yl)propanoic acid | 439108-20-0 | C7H8N2O2 |
|
3-喹噁宁羧酸甲酯盐酸盐 | 3-(methoxycarbonyl)quinuclidine hydrochloride | 54954-73-3 | C9H15NO2*ClH |
|
3-喹啉羰酰氯 | quinoline-3-carbonyl chloride | 84741-86-6 | C10H6ClNO |
|
3-喹啉羧酸乙酯 | ethyl 3-quinolinecarboxylate | 50741-46-3 | C12H11NO2 |
|
3-喹啉羧酸,1-(6-氨基-3,5-二氟-2-吡啶基)-8-氯-6,-7-二氟-1,4-二氢-4-氧代乙酯 | 6,7-difluoro-1-(6-amino-3,5-difluoropyridin-2-yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid ethyl ester | 906088-96-8 | C17H11F4N3O3 |
|
3-喹啉羧酸 | Norfloxacin nicotinate | 118803-81-9 | C22H23FN4O5 |
|
3-喹啉甲醛 | 3-quinolylcarboxaldehyde | 13669-42-6 | C10H7NO |
|
3-喹啉-3-基-丙酸 | 3-Quinolin-3-yl-propionic acid | 67752-28-7 | C12H11NO2 |
|
3-喹啉-2-丙酸 | 3-(quinoline-2-yl)propanoic acid | 39111-94-9 | C12H11NO2 |
|
3-喹啉-2-丙烯酸甲酯 | (E)-3-(3-quinolinyl)-2-propenoic acid methyl ester | 66417-78-5 | C13H11NO2 |
|
3-喹啉-2-丙烯酸 | (E)-3-(2-quinolinyl)-2-propenoic acid | 81124-50-7 | C12H9NO2 |
|
3-哒嗪酮-6-甲酸乙酯 | ethyl 1,6-dihydro-6-oxopyridazine-3-carboxylate | 63001-31-0 | C7H8N2O3 |
|
3-哒嗪酮 | 2H-Pyridazin-3-one | 504-30-3 | C4H4N2O |
|
3-哒嗪甲胺 | pyridazin-3-ylmethanamine | 93319-65-4 | C5H7N3 |
|
3-哌嗪基丙酸甲酯 | 1-(2-methoxycarbonylethyl)piperazine | 43032-40-2 | C8H16N2O2 |
|
3-哌嗪-1-基-哒嗪 | 3-Piperazin-1-ylpyridazine dihydrochloride | 90434-90-5 | C8H14Cl2N4 |
|
3-哌嗪-1,2-苯异唑 | 4(1,2-benzisoxazol-3-yl)piperazine | 87691-89-2 | C11H13N3O |
|
3-哌啶甲醇 | 3-(hydroxymethy)piperidine | 4606-65-9 | C6H13NO |
|
3-哌啶甲酸 | nipecotic acid | 498-95-3 | C6H11NO2 |
|
3-哌啶甲酰胺 | nipecotamide | 4138-26-5 | C6H12N2O |
|
3-吲哚乙酸钾 | potassium 1H-indol-3-ylacetate | 2338-19-4 | C10H9KNO2 |
|
3-吲哚丙酸 | Indole-3-propionic acid | 830-96-6 | C11H11NO2 |
|
3-吲哚丙烯酸 | indole-3-acrylic acid | 1204-06-4 | C11H9NO2 |
|
3-吲哚-乳酸 | indole-3-lactic acid | 1821-52-9 | C11H11NO3 |
|
3-吡嗪羧酰胺 1-氧化物 | 2-pyrazinecarboxamide-4-oxide | 768-36-5 | C5H5N3O2 |
|
3-吡啶醛肟 | 3-pyridinealdoxime | 1193-92-6 | C6H6N2O |
|
3-吡啶磺酸 | 3-pyridinesulfonic acid | 636-73-7 | C5H5NO3S |
|
3-吡啶硼酸 | 3-pyridylboronic acid | 1692-25-7 | C5H6BNO2 |
|
3-吡啶甲醇氮氧化物 | 3-pyridylcarbinol-N-oxide | 6968-72-5 | C6H7NO2 |
|
3-吡啶甲酸酐 | nicotinic anhydride | 16837-38-0 | C12H8N2O3 |
|
3-吡啶溴化镁 | magnesium,3H-pyridin-3-ide,bromide | 21970-14-9 | C5H4BrMgN |
|
3-吡啶氧基乙酸 | (Pyridin-3-yloxy)-acetic acid | 86649-57-2 | C7H7NO3 |
|
3-吡啶基羟基甲烷磺酸 | hydroxy-[3]pyridyl-methanesulfonic acid | 4812-14-0 | C6H7NO4S |
|
3-吡啶基偕胺肟 | nicotinamide oxime | 1594-58-7 | C6H7N3O |
|
3-吡啶基(2-硫酮-3-噻唑烷基)甲酮 | 3-(3-pyridinylcarbonyl)-1,3-thiazolidine-2-thione | 367906-48-7 | C9H8N2OS2 |
|
3-吡啶乙酸乙酯 | ETHYL 3-PYRIDYLACETATE | 39931-77-6 | C9H11NO2 |
|
3-吡啶乙酰腈,a-羟基- | 2-hydroxy-2-(pyridin-3-yl)acetonitrile | 17604-74-9 | C7H6N2O |
|
3-吡啶乙腈 | 3-pyridinylacetonitrile | 6443-85-2 | C7H6N2 |
|
3-吡啶丙醇 | 3-(3-pyridyl)propan-1-ol | 2859-67-8 | C8H11NO |
|
3-吡啶-4-基苯胺 | 3-(pyridin-4-yl)benzenamine | 40034-44-4 | C11H10N2 |
|
3-吡啶-2-基丙酸甲酯 | methyl 3-(pyridin-2-yl)propanoate | 28819-26-3 | C9H11NO2 |
|
3-吡唑甲酸乙酯 | ethyl 1H-pyrazole-3-carboxylate | 5932-27-4 | C6H8N2O2 |
|
3-吡唑-1-苯胺 | 3-(1H-pyrazol-1-yl)aniline | 184097-88-9 | C9H9N3 |
|
3-吡咯烷甲酸甲酯 | methyl pyrrolidine-3-carboxylate | 98548-90-4 | C6H11NO2 |
|
3-吡咯烷-2-喹啉 | 3-Pyrrolidin-2-yl-quinoline | 499207-38-4 | C13H14N2 |
|
3-吡咯烷-1-甲酸苄酯 | 1-carboxybenzyl-3-pyrrolidine | 31970-04-4 | C12H13NO2 |
|
3-吗啉基苯甲醛 | 3-morpholinobenzaldehyde | 446866-87-1 | C11H13NO2 |
|
3-叠氮基-2-氯吡啶 | 3-azido-2-chloropyridine | 102934-51-0 | C5H3ClN4 |
|